StockTipsArenaBeta

BUY Aarti Pharmalabs Limited — ICICI Securities

BUYAarti Pharmalabs Limited

byICICI SecuritiesHorizon: NA (inferred 1 year)14 Nov 2025via Institutional / Brokerage Research

Entry₹713.2Inferred
Target₹970
Total upside +36.01%
Stop lossNot given
CMP₹858.82d ago
Active+20.42%+12.95%upside left 2 mo left
Follow ICICI Securities for new calls(68% target hit, 1020 closed calls)Get alertsWatch AARTIPHARM for new buy/sell callsGet alertsSee 1 other Long-term call on AARTIPHARM

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 12:37 am IST
6 supporting2 neutral1 opposing
Supports the BUY call (6)

Aarti Pharmalabs targets 15-18% revenue and EBITDA growth over 3-4 years

NewsGoogle News·30 Aug · 1w ago

(opens in new tab)

Aarti Pharmalabs: FY26 Results Announced

NewsGoogle News·29 Aug · 1w ago

(opens in new tab)

Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?

NewsEt-Markets·11 Aug · 4w ago

(opens in new tab)

Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 crore

NewsEt-Markets·10 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (2)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·4 Sept · 2d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.